1-9 of 9
Xin Du
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B001: Intra- and inter-tumoral heterogeneity of melanoma across different metastatic sites

Veronica L. Aedo Lopez, Reem Saleh, Benjamin Blyth, Xin Du, Dane Vassiliadis, Katie Fennell, Davide Moi, Roberta Mazzieri, Riccardo Dolcetti, Karen E. Sheppard, Grant A. McArthur
Journal: Cancer Research
Cancer Res (2024) 84 (22_Supplement): B001.
https://doi.org/10.1158/1538-7445.TUMBODY-B001
Published: 17 November 2024
View article titled, Abstract B001: Intra- and inter-tumoral heterogeneity of melanoma across different metastatic sites
Journal Articles

Abstract C044: Single cell RNA-sequencing coupled with lineage tracing identifies novel clonal populations associated with immunotherapy resistance

Reem Saleh, Riyaben Patel, Dane Vassiliadis, Fayrouz Hammal, Benjamin Blyth, Xin Du, Katie Fennell, Mark A. Dawson, Grant A. McArthur, Karen Sheppard
Journal: Cancer Research
Cancer Res (2024) 84 (22_Supplement): C044.
https://doi.org/10.1158/1538-7445.TUMBODY-C044
Published: 17 November 2024
View article titled, Abstract C044: Single cell RNA-sequencing coupled with lineage tracing identifies novel clonal populations associated with immunotherapy resistance
Journal Articles

Abstract 6707: Inhibition of proteolytic cleavage of NKG2D ligands increases immune cell-mediated cell killing of tumor cells in vitro

Safak Yalcin, Vanessa Cicchini, Xin Du, Xin Wu, Tom Kaever, Neil Gibson
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 6707.
https://doi.org/10.1158/1538-7445.AM2020-6707
Published: 15 August 2020
View article titled, Abstract 6707: Inhibition of proteolytic cleavage of NKG2D ligands increases immune cell-mediated cell killing of tumor cells in vitro
Journal Articles

Abstract CT041: The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial

Yuankai Shi, Jianqiu Wu, Zhen Wang, Liling Zhang, Zhao Wang, Mingzhi Zhang, Hong Cen, Zhigang Peng, Yufu Li, Lei Fan, Ye Guo, Liping Ma, Jie Cui, Yuhuan Gao, Haiyan Yang, Hongyu Zhang, Lin Wang, Weihua Zhang, Huilai Zhang, Liping Xie, Ming Jiang, Hui Zhou, Yuerong Shuang, Hang Su, Xiaoyan Ke, Chuan Jin, Xin Du, Xin Du, Li Liu, Yaming Xi, Zheng Ge, Ru Feng, Yang Zhang, Shengyu Zhou, Fan Xie, Chao Gao
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): CT041.
https://doi.org/10.1158/1538-7445.AM2020-CT041
Published: 15 August 2020
View article titled, Abstract CT041: The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial
Journal Articles

Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells

Chang Liu, Danian Nie, Juan Li, Xin Du, Yuhong Lu, Yangqiu Li, Jingfeng Zhou, Yanli Jin, Jingxuan Pan
Journal: Cancer Research
Cancer Res (2018) 78 (6): 1522–1536.
https://doi.org/10.1158/0008-5472.CAN-17-1733
Published: 14 March 2018
View article titled, Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells
Open the PDF for Antitumor Effects of Blocking Protein Neddylation in T315I-BCR-ABL Leukemia Cells and Leukemia Stem Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 618: Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T cells

Peng Li, Xin Du, Yun Xin, Jianyu Weng, Peilong Lai
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 618.
https://doi.org/10.1158/1538-7445.AM2017-618
Published: 01 July 2017
View article titled, Abstract 618: Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T cells
Journal Articles

ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway

Xiao-Qing Li, Xin Du, Dong-Mei Li, Peng-Zhou Kong, Yan Sun, Pei-Fang Liu, Qing-Shan Wang, Yu-Mei Feng
Journal: Cancer Research
Series: Author Choice
Cancer Res (2015) 75 (16): 3302–3313.
https://doi.org/10.1158/0008-5472.CAN-15-0240
Published: 13 August 2015
View article titled, ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway
Open the PDF for ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway in another window
Includes: Supplementary data
Journal Articles

Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species

Yanli Jin, Zhongzheng Lu, Ke Ding, Juan Li, Xin Du, Chun Chen, Xiaoyong Sun, Yongbin Wu, Jing Zhou, Jingxuan Pan
Journal: Cancer Research
Cancer Res (2010) 70 (6): 2516–2527.
https://doi.org/10.1158/0008-5472.CAN-09-3950
Published: 14 March 2010
View article titled, Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species
Open the PDF for Antineoplastic Mechanisms of Niclosamide in Acute Myelogenous Leukemia Stem Cells: Inactivation of the NF-κB Pathway and Generation of Reactive Oxygen Species in another window
Includes: Supplementary data
Journal Articles

Abstract #2711A: Computer-aided drug discovery of MIF inhibitors as novel anti-cancer agents.

Zoe Cournia, Sunil Grandavadi, Lin Leng, Xin Du, Richard Bucala, William Jorgensen
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2711A.
Published: 01 May 2009
View article titled, Abstract #2711A: Computer-aided drug discovery of MIF inhibitors as novel anti-cancer agents.